Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04048356 · ClinicalTrials.gov registry record · Phase 3
Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures
A Phase 3 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 3
- Development phase
- 137
- Enrollment target
NCT04048356: Completed Phase 3 study, sponsored by University of New Mexico.
NCT04048356 is a Phase 3 study that has completed, run by University of New Mexico. The registered enrollment target is 137 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04048356, a Phase 3 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 137 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to determine if there is a difference between chlorhexidine gluconate and povidone iodine vaginal preparations for urogynecological surgery post operative infections.
Primary Outcome
Urinary tract infection as defined by positive urine culture of \>10,000 cfu, or empirically treated symptoms.
Interventions
- DRUG Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2021-03-14 |
| Phase | Phase 3 |
What the finished NCT04048356 record still lists
NCT04048356 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery. is the first listed.
NCT04048356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04048356 about?
NCT04048356 is a clinical study titled "Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures". This is a randomized controlled trial to determine if there is a difference between chlorhexidine gluconate and povidone iodine vaginal preparations for urogynecological surgery post operative infections.
What is the current status of trial NCT04048356?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 137 participants. The study started on 2019-07-15. Estimated completion is 2021-03-14.
What interventions are being tested in trial NCT04048356?
The interventions under investigation include: Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery. (DRUG).
Who is sponsoring clinical trial NCT04048356?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04048356's enrollment target sits among peer trials
137 1580th of 2000 higher than 421 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI